<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.5a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="bpth-20260331.xsd#Cover" roleURI="http://biopathholdings.com/role/Cover" />
    <link:roleRef xlink:type="simple" xlink:href="bpth-20260331.xsd#CondensedConsolidatedBalanceSheets" roleURI="http://biopathholdings.com/role/CondensedConsolidatedBalanceSheets" />
    <link:roleRef xlink:type="simple" xlink:href="bpth-20260331.xsd#CondensedConsolidatedBalanceSheetsParenthetical" roleURI="http://biopathholdings.com/role/CondensedConsolidatedBalanceSheetsParenthetical" />
    <link:roleRef xlink:type="simple" xlink:href="bpth-20260331.xsd#CondensedConsolidatedStatementsOfOperations" roleURI="http://biopathholdings.com/role/CondensedConsolidatedStatementsOfOperations" />
    <link:roleRef xlink:type="simple" xlink:href="bpth-20260331.xsd#CondensedConsolidatedStatementsOfCashFlows" roleURI="http://biopathholdings.com/role/CondensedConsolidatedStatementsOfCashFlows" />
    <link:roleRef xlink:type="simple" xlink:href="bpth-20260331.xsd#CondensedConsolidatedStatementsOfShareholdersDeficitEquity" roleURI="http://biopathholdings.com/role/CondensedConsolidatedStatementsOfShareholdersDeficitEquity" />
    <link:roleRef xlink:type="simple" xlink:href="bpth-20260331.xsd#OrganizationAndBusiness" roleURI="http://biopathholdings.com/role/OrganizationAndBusiness" />
    <link:roleRef xlink:type="simple" xlink:href="bpth-20260331.xsd#SignificantAccountingPolicies" roleURI="http://biopathholdings.com/role/SignificantAccountingPolicies" />
    <link:roleRef xlink:type="simple" xlink:href="bpth-20260331.xsd#PrepaidDrugProduct" roleURI="http://biopathholdings.com/role/PrepaidDrugProduct" />
    <link:roleRef xlink:type="simple" xlink:href="bpth-20260331.xsd#OtherCurrentAssets" roleURI="http://biopathholdings.com/role/OtherCurrentAssets" />
    <link:roleRef xlink:type="simple" xlink:href="bpth-20260331.xsd#AccountsPayable" roleURI="http://biopathholdings.com/role/AccountsPayable" />
    <link:roleRef xlink:type="simple" xlink:href="bpth-20260331.xsd#NotesPayable" roleURI="http://biopathholdings.com/role/NotesPayable" />
    <link:roleRef xlink:type="simple" xlink:href="bpth-20260331.xsd#AccruedExpense" roleURI="http://biopathholdings.com/role/AccruedExpense" />
    <link:roleRef xlink:type="simple" xlink:href="bpth-20260331.xsd#WarrantLiability" roleURI="http://biopathholdings.com/role/WarrantLiability" />
    <link:roleRef xlink:type="simple" xlink:href="bpth-20260331.xsd#FairValueMeasurements" roleURI="http://biopathholdings.com/role/FairValueMeasurements" />
    <link:roleRef xlink:type="simple" xlink:href="bpth-20260331.xsd#StockholdersEquity" roleURI="http://biopathholdings.com/role/StockholdersEquity" />
    <link:roleRef xlink:type="simple" xlink:href="bpth-20260331.xsd#Stock-basedCompensationPlan" roleURI="http://biopathholdings.com/role/Stock-basedCompensationPlan" />
    <link:roleRef xlink:type="simple" xlink:href="bpth-20260331.xsd#CommitmentsAndContingencies" roleURI="http://biopathholdings.com/role/CommitmentsAndContingencies" />
    <link:roleRef xlink:type="simple" xlink:href="bpth-20260331.xsd#SubsequentEvents" roleURI="http://biopathholdings.com/role/SubsequentEvents" />
    <link:roleRef xlink:type="simple" xlink:href="bpth-20260331.xsd#SignificantAccountingPoliciesPolicies" roleURI="http://biopathholdings.com/role/SignificantAccountingPoliciesPolicies" />
    <link:roleRef xlink:type="simple" xlink:href="bpth-20260331.xsd#FairValueMeasurementsTables" roleURI="http://biopathholdings.com/role/FairValueMeasurementsTables" />
    <link:roleRef xlink:type="simple" xlink:href="bpth-20260331.xsd#Stock-basedCompensationPlanTables" roleURI="http://biopathholdings.com/role/Stock-basedCompensationPlanTables" />
    <link:roleRef xlink:type="simple" xlink:href="bpth-20260331.xsd#PrepaidDrugProductDetailsNarrative" roleURI="http://biopathholdings.com/role/PrepaidDrugProductDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="bpth-20260331.xsd#OtherCurrentAssetsDetailsNarrative" roleURI="http://biopathholdings.com/role/OtherCurrentAssetsDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="bpth-20260331.xsd#AccountsPayableDetailsNarrative" roleURI="http://biopathholdings.com/role/AccountsPayableDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="bpth-20260331.xsd#NotesPayableDetailsNarrative" roleURI="http://biopathholdings.com/role/NotesPayableDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="bpth-20260331.xsd#AccruedExpenseDetailsNarrative" roleURI="http://biopathholdings.com/role/AccruedExpenseDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="bpth-20260331.xsd#WarrantLiabilityDetailsNarrative" roleURI="http://biopathholdings.com/role/WarrantLiabilityDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="bpth-20260331.xsd#FairValueMeasurements-WarrantsMeasuredAtFairValueDetails" roleURI="http://biopathholdings.com/role/FairValueMeasurements-WarrantsMeasuredAtFairValueDetails" />
    <link:roleRef xlink:type="simple" xlink:href="bpth-20260331.xsd#FairValueMeasurements-ChangesToFairValueOfLevelWarrantsDetails" roleURI="http://biopathholdings.com/role/FairValueMeasurements-ChangesToFairValueOfLevelWarrantsDetails" />
    <link:roleRef xlink:type="simple" xlink:href="bpth-20260331.xsd#FairValueMeasurements-ChangeToFairValueOfLevel3DeritivativeLiabilitiesDetails" roleURI="http://biopathholdings.com/role/FairValueMeasurements-ChangeToFairValueOfLevel3DeritivativeLiabilitiesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="bpth-20260331.xsd#FairValueMeasurements-Black-scholesValuationModelEstimatingFairValueDetails" roleURI="http://biopathholdings.com/role/FairValueMeasurements-Black-scholesValuationModelEstimatingFairValueDetails" />
    <link:roleRef xlink:type="simple" xlink:href="bpth-20260331.xsd#StockholdersEquityDetailsNarrative" roleURI="http://biopathholdings.com/role/StockholdersEquityDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="bpth-20260331.xsd#Stock-basedCompensationPlan-OptionActivityDetails" roleURI="http://biopathholdings.com/role/Stock-basedCompensationPlan-OptionActivityDetails" />
    <link:roleRef xlink:type="simple" xlink:href="bpth-20260331.xsd#Stock-basedCompensationPlanDetailsNarrative" roleURI="http://biopathholdings.com/role/Stock-basedCompensationPlanDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="bpth-20260331.xsd#CommitmentsAndContingenciesDetailsNarrative" roleURI="http://biopathholdings.com/role/CommitmentsAndContingenciesDetailsNarrative" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biopathholdings.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biopathholdings.com/role/CondensedConsolidatedBalanceSheets" xlink:title="00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCash" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherAssetsCurrent" xlink:label="loc_us-gaapOtherAssetsCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapOtherAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NotesPayableCurrent" xlink:label="loc_us-gaapNotesPayableCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapNotesPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DerivativeLiabilities" xlink:label="loc_us-gaapDerivativeLiabilities" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapDerivativeLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="loc_us-gaapWarrantsAndRightsOutstanding" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapWarrantsAndRightsOutstanding" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://biopathholdings.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biopathholdings.com/role/CondensedConsolidatedStatementsOfOperations" xlink:title="00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:loc xlink:type="locator" xlink:href="bpth-20260331.xsd#BPTH_InterestExpense2" xlink:label="loc_BPTHInterestExpense2" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_BPTHInterestExpense2" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://biopathholdings.com/role/CondensedConsolidatedStatementsOfCashFlows" xlink:title="00000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AmortizationOfDeferredCharges" xlink:label="loc_us-gaapAmortizationOfDeferredCharges" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapAmortizationOfDeferredCharges" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAssetAmortizationExpense" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaapFairValueAdjustmentOfWarrants" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapFairValueAdjustmentOfWarrants" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:label="loc_us-gaapIncreaseDecreaseInOtherCurrentAssets" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherCurrentAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingLeaseLiability" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingLeaseLiability" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaapProceedsFromWarrantExercises" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromWarrantExercises" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="loc_us-gaapProceedsFromNotesPayable" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromNotesPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://biopathholdings.com/role/CondensedConsolidatedStatementsOfShareholdersDeficitEquity" xlink:title="00000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS (DEFICIT) EQUITY" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biopathholdings.com/role/OrganizationAndBusiness" xlink:title="999007 - Disclosure - 1. Organization and Business" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biopathholdings.com/role/SignificantAccountingPolicies" xlink:title="999008 - Disclosure - 2. Significant Accounting Policies" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biopathholdings.com/role/PrepaidDrugProduct" xlink:title="999009 - Disclosure - 3. Prepaid Drug Product" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biopathholdings.com/role/OtherCurrentAssets" xlink:title="999010 - Disclosure - 4. Other Current Assets" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biopathholdings.com/role/AccountsPayable" xlink:title="999011 - Disclosure - 5. Accounts Payable" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biopathholdings.com/role/NotesPayable" xlink:title="999012 - Disclosure - 6. Notes Payable" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biopathholdings.com/role/AccruedExpense" xlink:title="999013 - Disclosure - 7. Accrued Expense" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biopathholdings.com/role/WarrantLiability" xlink:title="999014 - Disclosure - 8. Warrant Liability" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biopathholdings.com/role/FairValueMeasurements" xlink:title="999015 - Disclosure - 9. Fair Value Measurements" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biopathholdings.com/role/StockholdersEquity" xlink:title="999016 - Disclosure - 10. Stockholders&#8217; Equity" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biopathholdings.com/role/Stock-basedCompensationPlan" xlink:title="999017 - Disclosure - 11. Stock-Based Compensation Plan" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biopathholdings.com/role/CommitmentsAndContingencies" xlink:title="999018 - Disclosure - 12. Commitments and Contingencies" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biopathholdings.com/role/SubsequentEvents" xlink:title="999019 - Disclosure - 13. Subsequent Events" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biopathholdings.com/role/SignificantAccountingPoliciesPolicies" xlink:title="999020 - Disclosure - 2. Significant Accounting Policies (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biopathholdings.com/role/FairValueMeasurementsTables" xlink:title="999021 - Disclosure - 9. Fair Value Measurements (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biopathholdings.com/role/Stock-basedCompensationPlanTables" xlink:title="999022 - Disclosure - 11. Stock-Based Compensation Plan (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biopathholdings.com/role/PrepaidDrugProductDetailsNarrative" xlink:title="999023 - Disclosure - 3. Prepaid Drug Product (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biopathholdings.com/role/OtherCurrentAssetsDetailsNarrative" xlink:title="999024 - Disclosure - 4. Other Current Assets (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biopathholdings.com/role/AccountsPayableDetailsNarrative" xlink:title="999025 - Disclosure - 5. Accounts Payable (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biopathholdings.com/role/NotesPayableDetailsNarrative" xlink:title="999026 - Disclosure - 6. Notes Payable (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biopathholdings.com/role/AccruedExpenseDetailsNarrative" xlink:title="999027 - Disclosure - 7. Accrued Expense (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biopathholdings.com/role/WarrantLiabilityDetailsNarrative" xlink:title="999028 - Disclosure - 8. Warrant Liability (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biopathholdings.com/role/FairValueMeasurements-WarrantsMeasuredAtFairValueDetails" xlink:title="999029 - Disclosure - 9. Fair Value Measurements - Warrants Measured at Fair Value (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biopathholdings.com/role/FairValueMeasurements-ChangesToFairValueOfLevelWarrantsDetails" xlink:title="999030 - Disclosure - 9. Fair Value Measurements - Changes to Fair Value of Level Warrants (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biopathholdings.com/role/FairValueMeasurements-ChangeToFairValueOfLevel3DeritivativeLiabilitiesDetails" xlink:title="999031 - Disclosure - 9. Fair Value Measurements - Change to Fair Value of Level 3 Deritivative Liabilities (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biopathholdings.com/role/FairValueMeasurements-Black-scholesValuationModelEstimatingFairValueDetails" xlink:title="999032 - Disclosure - 9. Fair Value Measurements - Black-Scholes Valuation Model Estimating Fair Value (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biopathholdings.com/role/StockholdersEquityDetailsNarrative" xlink:title="999033 - Disclosure - 10. Stockholders&#8217; Equity (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biopathholdings.com/role/Stock-basedCompensationPlan-OptionActivityDetails" xlink:title="999034 - Disclosure - 11. Stock-Based Compensation Plan - Option Activity (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biopathholdings.com/role/Stock-basedCompensationPlanDetailsNarrative" xlink:title="999035 - Disclosure - 11. Stock-Based Compensation Plan (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://biopathholdings.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="999036 - Disclosure - 12. Commitments and Contingencies (Details Narrative)" />
</link:linkbase>
